GPT Healthcare Reports Q3FY26 Results with Revenue Growth of 16.81% YoY
GPT Healthcare announced Q3FY26 results showing revenue growth of 16.81% to ₹121.6 Cr, though profitability declined with PAT dropping 23.50% to ₹9.4 Cr. The company maintained operational momentum with ARPOB at ₹38,797 and continued network expansion including CTVS commissioning at ILS-Dum Dum.

*this image is generated using AI for illustrative purposes only.
GPT Healthcare Limited has announced its Q3FY26 financial results, reporting revenue of ₹121.6 Cr for the quarter ended December 31, 2025, marking a 16.81% year-on-year growth. The company submitted its comprehensive financial results and press release under Regulation 30 of SEBI regulations on February 2, 2026.
Q3FY26 Financial Performance
The company demonstrated strong revenue momentum with quarterly revenue reaching ₹121.6 Cr compared to ₹104.1 Cr in Q3FY25. However, profitability metrics showed pressure with EBITDA declining 4.38% to ₹22.2 Cr and PAT dropping 23.50% to ₹9.4 Cr. EBITDA margins compressed to 18.20% from 22.23% in the previous year.
| Metric: | Q3FY26 | Q3FY25 | YoY Change |
|---|---|---|---|
| Total Revenue: | ₹121.6 Cr | ₹104.1 Cr | +16.81% |
| EBITDA: | ₹22.2 Cr | ₹23.1 Cr | -4.38% |
| EBITDA Margin: | 18.20% | 22.23% | Compression |
| PAT: | ₹9.4 Cr | ₹12.1 Cr | -23.50% |
Nine-Month Performance Overview
For 9MFY26, the company achieved total revenue of ₹350.5 Cr, representing 12.12% year-on-year growth from ₹312.6 Cr in 9MFY25. Despite revenue growth, EBITDA declined 6.39% to ₹65.1 Cr with margins compressing from 22.26% to 18.58%. PAT for the nine-month period stood at ₹27.6 Cr, down 25.32% from ₹37.0 Cr in the previous year.
| Parameter: | 9MFY26 | 9MFY25 | Change |
|---|---|---|---|
| Total Revenue: | ₹350.5 Cr | ₹312.6 Cr | +12.12% |
| EBITDA: | ₹65.1 Cr | ₹69.6 Cr | -6.39% |
| PAT: | ₹27.6 Cr | ₹37.0 Cr | -25.32% |
Operational Highlights and Network Expansion
The company maintained competitive ARPOB at ₹38,797 while achieving 55% occupancy excluding the newly commenced Raipur facility. Including Raipur, overall network occupancy stands at 45%. The company commissioned CTVS (Cardiothoracic and Vascular Surgery) services at ILS-Dum Dum, providing complete cardiac care under one roof. The Raipur facility continues scaling efficiently while the Jamshedpur project progresses as planned.
Management Commentary
Chairman Dr. Om Tantia highlighted the company's disciplined execution and improving operating metrics. He emphasized the completion of over 750+ robotic surgeries at ILS Salt Lake, reinforcing the company's position in advanced minimally invasive care. The payer mix remained predominantly cash and insurance, reflecting revenue quality and financial resilience while serving the aspirational middle-to-high income population.
Historical Stock Returns for GPT Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.04% | +0.37% | -3.98% | -19.57% | -7.35% | -35.53% |


































